Page last updated: 2024-10-24

carmustine and Acute Relapsing Multiple Sclerosis

carmustine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moore, JJ1
Massey, JC1
Ford, CD1
Khoo, ML1
Zaunders, JJ1
Hendrawan, K1
Barnett, Y1
Barnett, MH1
Kyle, KA1
Zivadinov, R1
Ma, KC1
Milliken, ST1
Sutton, IJ1
Ma, DDF1

Trials

1 trial available for carmustine and Acute Relapsing Multiple Sclerosis

ArticleYear
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
    Journal of neurology, neurosurgery, and psychiatry, 2019, Volume: 90, Issue:5

    Topics: Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine;

2019